Document Detail


Cholesterol embolization syndrome. Occurrence after intravenous streptokinase therapy for myocardial infarction.
MedLine Citation:
PMID:  3656605     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two patients developed the cholesterol embolization syndrome after coronary angiography and intravenous streptokinase therapy for acute myocardial infarction. Clinical manifestations included cyanosis, ulcers, gangrene of the hands and feet, myalgias, intestinal infarction, eosinophilia, and renal failure. One patient died; one has survived with chronic renal failure. Streptokinase therapy may expose atheromatous plaques to the circulation by lysing platelet-fibrin thrombi.
Authors:
M W Schwartz; G B McDonald
Related Documents :
3315575 - Early clinical evaluation of the intravenous treatment of acute myocardial infarction w...
3315585 - Acute coronary occlusion and reperfusion. reliability of angiographic classification an...
14728075 - Does magnesium have a role in the treatment of patients with coronary artery disease?
22104165 - Improved left ventricular mass quantification with partial voxel interpolation: in vivo...
7955235 - Arrhythmias and sudden death after dynamic cardiomyoplasty.
7736485 - Circadian variation and triggers of cardiovascular disease.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  JAMA : the journal of the American Medical Association     Volume:  258     ISSN:  0098-7484     ISO Abbreviation:  JAMA     Publication Date:  1987 Oct 
Date Detail:
Created Date:  1987-10-29     Completed Date:  1987-10-29     Revised Date:  2006-11-07    
Medline Journal Info:
Nlm Unique ID:  7501160     Medline TA:  JAMA     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1934-5     Citation Subset:  AIM; IM    
Affiliation:
Department of Medicine, Veterans Administration Medical Center, Seattle, WA 98108.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cholesterol*
Coronary Angiography*
Embolism, Fat / etiology*
Female
Humans
Male
Middle Aged
Myocardial Infarction / drug therapy
Streptokinase / adverse effects*,  therapeutic use
Chemical
Reg. No./Substance:
57-88-5/Cholesterol; EC 3.4.-/Streptokinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dipstick leukocyte esterase activity in first-catch urine specimens. A useful screening test for det...
Next Document:  Pregnancy and birth rates among sexually experienced US teenagers--1974, 1980, and 1983.